Wikidata:WikiProject Medicine/Vaccine list
This list is periodically updated by a bot. Manual changes to the list will be removed on the next update!
WDQS | PetScan | TABernacle | Find images | Recent changes | Query:SELECT ?item WHERE { ?item wdt:P279* wd:Q134808 }| label | description | ATC code | route of administration | manufacturer | vaccine for |
|---|---|---|---|---|---|
| 2009 flu pandemic vaccine | vaccine to protect against 2009 H1N1 pandemic influenza | pandemic H1N1/09 virus | |||
| 202-CoV | vaccine candidate against COVID-19 | COVID-19 | |||
| 72F fusion protein | candidate tuberculosis vaccine | ||||
| ABNCoV2 | vaccine candidate against COVID-19 | COVID-19 | |||
| ACAM2000 smallpox vaccine | smallpox vaccine | ||||
| ACWY vaccine | |||||
| AG0301-COVID19 | experimental COVID-19 vaccine | AnGes Takara Bio Cytiva Brickell Biotech, Inc. |
COVID-19 | ||
| AG0302-COVID‑19 | vaccine candidate against COVID-19 | COVID-19 | |||
| AGS-v | vaccine candidate | ||||
| AIDSVAX | experimental vaccine developed by Genentech against Human Immunodeficiency Virus (HIV) | ||||
| ARCT-154 | vaccine candidate against COVID-19 | COVID-19 | |||
| AZD1222 | viral vector vaccine for prevention of COVID-19 | intramuscular injection | Oswaldo Cruz Foundation Serum Institute of India HALIX B.V. Advent SRL Merck KGaA Vaccitech AstraZeneca SK Bioscience JCR Pharmaceuticals |
COVID-19 | |
| Abdala | vaccine candidate against COVID-19 | COVID-19 | |||
| Ad26.COV2.S | COVID-19 vaccine of Johnson & Johnson | intramuscular injection | Emergent BioSolutions Catalent Pharma Solutions Biological E. Limited Grand River Aseptic Manufacturing |
COVID-19 | |
| Ad5-nCoV | Chinese adenovirus-based vaccine against COVID-19 | J07BX03 | intramuscular injection | Petrovax | COVID-19 |
| AdimrSC-2f | experimental COVID-19 vaccine | COVID-19 | |||
| Agrippal S1 | Novartis | ||||
| Alzheimer vaccines | vaccines or candidate vaccines used to prevent or treat Alzheimer's disease | Alzheimer's disease | |||
| Androvax | vaccine | ||||
| Anhui Zhifei Longcom Biopharmaceutical COVID-19 vaccine candidate | candidate vaccine against COVID-19 | Anhui Zhifei Longcom Biopharmaceutical | COVID-19 | ||
| Anthrax Vaccine Adsorbed | vaccine | ||||
| Antigen-presenting cell vaccine | |||||
| ArVac Cecilia Grierson | COVID-19 vaccine based on recombinant protein technology | intramuscular injection | COVID-19 | ||
| Arcov | candidate vaccine against COVID-19 | Walvax Biotechnology Co., Ltd. | COVID-19 | ||
| Avicine | vaccine | ||||
| BBIBP-CorV | Chinese inactivated virus candidate vaccine against COVID-19 | intramuscular injection | COVID-19 | ||
| BBV154 | vaccine candidate against COVID-19 | nasal administration | Bharat Biotech International | COVID-19 | |
| BCG vaccine | vaccine primarily used against tuberculosis | J07AN01 L03AX03 |
tuberculosis | ||
| BriLife | experimental COVID-19 vaccine | injection | Israel Institute for Biological Research | COVID-19 | |
| Brucella vaccine | bacterial vaccine for the prevention of brucellosis in man and animal | brucellosis | |||
| Brucellosis vaccine | vaccine for cattle, sheep and goats used against brucellosis | J07AD | brucellosis | ||
| CHIKV/IRES vaccine candidate | vaccine candidate for chikungunya | ||||
| COH04S1 | vaccine candidate against COVID-19 | ||||
| COVAX-19 | candidate vaccine against COVID-19 | Medytox Korea Co., Ltd. Sypharma Oxford Expression Technologies Ltd. |
COVID-19 | ||
| COVAX-19 | vaccine candidate against COVID-19 | COVID-19 | |||
| COVI-VAC | candidate vaccine against COVID-19 | nasal administration | |||
| COVID-19 vaccine | vaccine against SARS-CoV-2 coronavirus | J07BN | COVID-19 | ||
| COVIran Barekat | COVID-19 vaccine developed by Iranian state-owned Shifa Pharmed Industrial Group | COVID-19 | |||
| CY-1899 | immunotherapeutic vaccine | ||||
| CYT006-AngQb | vaccine | ||||
| Calf lymph | |||||
| Cervarix | HPV vaccine | J07BM02 | intramuscular injection | ||
| ChAdOx1 biEBOV | Ebola hemorrhagic fever | ||||
| Chinese Academy of Medical Sciences COVID-19 vaccine | vaccine candidate against COVID-19 | COVID-19 | |||
| CimaVax-EGF | lung cancer vaccine developed in Cuba | non-small-cell lung carcinoma | |||
| CoVAXIX | COVID-19 | ||||
| Corbevax | candidate vaccine against COVID-19 | J07BX03 | intramuscular injection | COVID-19 | |
| CoronaVac | Sinovac vaccine against COVID-19 | J07BX03 | intramuscular injection | Sinovac Biotech | COVID-19 |
| Coronavirus-induced disease vaccine | any vaccine against a a contagious disease caused by any coronavirus | coronavirus disease | |||
| Covaxin / BBV152 | vaccine against COVID-19 | intramuscular injection | Bharat Biotech International | COVID-19 | |
| CoviVac | vaccine rusa | intramuscular injection | COVID-19 | ||
| CoviVac | vaccine against COVID-19 | COVID-19 | |||
| Cytomegalovirus vaccine | vaccine to prevent cytomegalovirus (CMV) infection | human betaherpesvirus 5 | |||
| DNA vaccine | novel type of vaccine | ||||
| DPT vaccine | vaccine against diphtheria, pertussis, and tetanus | J07AM01 | diphtheria tetanus pertussis | ||
| DTaP-IPV-HepB vaccine | Combination vaccine | J07CA12 | |||
| DTaP-IPV/Hib vaccine | combination vaccine | ||||
| DTwP-HepB-Hib vaccine | combination vaccine | ||||
| DelNS1-2019-nCoV-RBD-OPT | vaccine candidate against COVID-19 | nasal administration | COVID-19 | ||
| Dengvaxia | Dengue vaccine | ||||
| Diphtheria-Tetanus-acellular Pertussis vaccines | combined vaccines | diphtheria tetanus | |||
| Dryvax | |||||
| ENGERIX®-B vaccine | vaccine | hepatitis B | |||
| ERVEVAX | GlaxoSmithKline Biologicals | rubella | |||
| Ebola vaccine | vaccine to prevent Ebola | Ebola hemorrhagic fever | |||
| Edible algae vaccine | vaccination strategy under preliminary research to combine a genetically engineered sub-unit vaccine and an immunologic adjuvant into Chlamydomonas reinhardtii microalgae | ||||
| Edible vaccines | |||||
| EpiVacCorona | experimental Russian COVID-19 vaccine | intramuscular injection deltoid muscle quadriceps femoris muscle |
COVID-19 | ||
| Epstein–Barr vaccine | proposed vaccine against Epstein–Barr virus | Epstein–Barr virus infection | |||
| Escherichia coli vaccines | vaccines or candidate vaccines used for Escherichia coli infections | Escherichia coli infectious disease | |||
| EuCorVac-19 | vaccine candidate against COVID-19 | ||||
| FAKHRAVAC | vaccine candidate against COVID-19 | intramuscular injection | COVID-19 | ||
| Finlay-FR-1 | experimental COVID-19 vaccine | COVID-19 | |||
| Flublok | influenca vaccine | ||||
| Fluzone | seasonal influenza vaccine | ||||
| GLS-5700 | potential Zika vaccine | ||||
| GRAd-COV2 | experimental COVID-19 vaccine | Univercells (Belgium) | COVID-19 | ||
| GX-19 | candidate vaccine against COVID-19 | BINEX Co. Ltd. PT Kalbe Farma Tbk |
COVID-19 | ||
| Gam-COVID-Vac | Russian viral vector vaccine based on human adenovirus | J07BX03 | intramuscular injection | COVID-19 | |
| GamEvac-Combi | heterologous VSV- and Ad5-vectored Ebola vaccine | ||||
| Gardasil | HPV vaccine | J07BM01 | intramuscular injection | ||
| Genetic vaccine | |||||
| Gp100:209-217(210M) | peptide cancer vaccine | ||||
| Group B streptococcus vaccine | Group B streptococcal infection | ||||
| H5N1 vaccine | influenza vaccine | influenza A virus subtype H5N1 | |||
| HGC019 | candidate vaccine against COVID-19 | ||||
| HIV vaccine | in-progress vaccinations that may prevent or treat HIV infections | human immunodeficiency virus infectious disease | |||
| HPV vaccine | class of vaccines against human papillomavirus | J07BM | anogenital venereal wart human papillomavirus infection | ||
| Haemophilus B and hepatitis B vaccine | |||||
| Haemophilus vaccines | vaccines or candidate vaccines containing antigenic polysaccharides from Haemophilus influenzae and designed to prevent infection | Haemophilus influenzae infectious disease | |||
| Hantavax | Hantavirus vaccine which is produced by Green Cross | Green Cross | |||
| Hantavirus vaccine | vaccine that protects humans against hantavirus infections | Hantavirus | |||
| Hasumi vaccine | |||||
| Hepacivac | European Initiative to Create Hepatitis C Vaccine | ||||
| Hepatitis B vaccine | vaccine against Hepatitis B | J07BC01 | hepatitis B | ||
| Hepatyrix | J07CA10 | ||||
| Herpes Simplex Virus vaccines | vaccines or candidate vaccines used to prevent infection with viruses from the genus Simplexvirus; includes vaccines for HSV-1 and HSV-2 | Herpes simplex virus type 1 | |||
| Herpesvirus vaccines | vaccines or candidate vaccines used to prevent infection by any virus from the family Herpesviridae | Herpesviridae infectious disease | |||
| Hib vaccine | vaccine | J07AG01 | Haemophilus influenzae | ||
| Historical annual reformulations of the influenza vaccine | |||||
| HspE7 | investigational HPV vaccine | ||||
| HybriCell | |||||
| INFANRIX HEXA | hexavalent vaccine by GlaxoSmithKline | J07CA09 | GSK | ||
| INNA-051 | vaccine candidate against COVID-19 | ||||
| INO-4800 | experimental vaccine against COVID-19 | VGXI, Inc. Richter-Helm BioLogics GmbH & Co. KG. Ology Bioservices, Inc. Thermo Fisher Scientific Inc. |
COVID-19 | ||
| IVX-411 | COVID-19 nanoparticle vaccine candidate | COVID-19 | |||
| ImmunityBio COVID-19 vaccine | viral vector COVID-19 vaccine developed by ImmunityBio | ||||
| Immunization registry | immunization information system | ||||
| Imovax | vaccine against rabies for humans | Sanofi Pasteur | |||
| Imvanex | |||||
| Influvac | Influenza vaccine | J07BB02 | intramuscular injection subcutaneous injection |
Abbott Laboratories | |
| Institute of Medical Biology COVID-19 vaccine candidate | candidate vaccine against COVID-19 | COVID-19 | |||
| Inverse vaccine | |||||
| Japanese encephalitis vaccine | any of several vaccines against Japanese encephalitis | J07BA02 J07BA03 |
Japanese encephalitis | ||
| KD-414 | vaccine candidate against COVID-19 | ||||
| LNP-nCoVsaRNA | candidate vaccine against COVID-19 | COVID-19 | |||
| LYB001 | vaccine candidate against COVID-19 | ||||
| Leishmaniasis vaccines | vaccines or candidate vaccines used to prevent infection with Leishmania | leishmaniasis | |||
| Live vector vaccine | |||||
| Lunar-COV19 | experimental COVID-19 vaccine | Catalent Pharma Solutions | COVID-19 | ||
| Lyme Disease vaccines | vaccines or candidate vaccines used to prevent Lyme Disease | Lyme disease | |||
| M-M-R II | Merck Sharp & Dohme B.V. | measles mumps rubella | |||
| M-M-RVAXPRO | MSD VACCINS | measles mumps rubella | |||
| MMR vaccine | any of several combined vaccines against measles, mumps, and rubella | J07BD52 | measles rubella mumps | ||
| MMRV vaccine | combination vaccine against measles, mumps, rubella, and varicella viruses | J07BD54 | measles mumps rubella chickenpox | ||
| MOPAVAC | Sevapharma | measles mumps | |||
| MVA-B | |||||
| MVA-BN smallpox vaccine | |||||
| MVA85A | mva | ||||
| MVC COVID-19 Vaccine | COVID-19 vaccine made by Medigen | intramuscular injection | Dynavax Technologies (United States) Medigen Vaccine Biologics |
COVID-19 | |
| Mambisa | vaccine against COVID-19 | nasal administration | Center for Genetic Engineering and Biotechnology | COVID-19 | |
| Marek Disease vaccines | vaccines or candidate vaccines used to prevent Marek Disease, an avian disease caused by a herpesvirus | Marek's disease | |||
| MeNZB | meningococcal vaccine | ||||
| Medicago Inc. COVID-19 vaccine candidate | candidate vaccine against COVID-19 | COVID-19 | |||
| MenAfriVac | vaccine developed for use in sub-Saharan Africa | ||||
| MigVax-101 | vaccine candidate against COVID-19 | ||||
| Minhai COVID-19 vaccine | vaccine candidate against COVID-19 | ||||
| Misinformation related to vaccination | false or misleading information related to vaccines | ||||
| Mumpsvax | |||||
| NDV-HXP-S | COVID-19 vaccine candidate | ||||
| NVX-CoV2373 | vaccine against COVID-19 | FUJIFILM Diosynth Biotechnologies (global) SK Bioscience Praha Vaccines Biofabri Takeda Pharmaceutical Company PolyPeptide Group Endo International plc Biologics Manufacturing Centre |
COVID-19 | ||
| Nasal vaccine | vaccine administered via the nose | nasal administration | |||
| Neurovax | vaccine brand | multiple sclerosis | |||
| Neuvenge | therapeutic cancer vaccine in development | ||||
| NicVAX | experimental nicotine dependency vaccine | ||||
| NmVac4-A/C/Y/W-135 | vaccine against bacterial meningitis | ||||
| Noora | vaccine candidate against COVID-19 | COVID-19 | |||
| OC-007 | |||||
| Optaflu | Novartis | ||||
| Oral vaccination against rabies | |||||
| OspA lipoprotein | pharmaceutical drug | ||||
| Ovandrotone albumin | immunogen and vaccine against androstenedione | ||||
| PAVIVAC | Sevapharma | mumps | |||
| PFSPZ vaccine | Malaria vaccine | ||||
| PR1 leukemia peptide vaccine | type of cancer vaccine | ||||
| Pandemrix | flu vaccine | J07BB02 | GSK | ||
| People's Vaccine | concept in vaccine equity | ||||
| Plant expressed vaccine | |||||
| PneumoADIP | |||||
| Poliovirus Vaccine, Inactivated | suspension of formalin-inactivated poliovirus grown in monkey kidney cell tissue culture and used to prevent poliomyelitis | ||||
| Priorix | MMR vaccine brand | measles mumps rubella | |||
| Priorix-Tetra | GSK | measles mumps rubella chickenpox | |||
| ProQuad | J07BD54 | Merck & Co. | measles mumps rubella chickenpox | ||
| Prostvac | prostate cancer vaccine | ||||
| Prototypvaccin | |||||
| Provenge | pharmaceutical product | ||||
| Pseudomonas vaccines | Vaccines or candidate vaccines used to prevent or treat Pseudomonas infections | Pseudomonas infection | |||
| Pseudorabies Vaccines | Vaccines or candidate vaccines used to prevent PSEUDORABIES (Aujeszky's disease), a herpesvirus of swine and other animals. | pseudorabies | |||
| Q fever vaccine | vaccine for preventing Q fever infection in humans | Q fever | |||
| QazCovid-in | experimental COVID-19 vaccine | COVID-19 | |||
| QazCovid-in | vaccine candidate against COVID-19 | ||||
| Quinvaxem | combination vaccine (tradename) | ||||
| R21/Matrix-M | malaria vaccine | intramuscular injection | Serum Institute of India | malaria | |
| RBCG30 | prospective tuberculosis vaccine | ||||
| RBD SARS-CoV-2 HBsAg VLP | experimental COVID-19 vaccine | COVID-19 | |||
| RNA vaccine | vaccine that transfects synthetic RNA to reprogram cells to make foreign protein that stimulates an adaptive immune response | ||||
| RTS,S | malaria vaccine | intramuscular injection | GSK | malaria | |
| Razi Cov Pars | vaccine candidate against COVID-19 | ||||
| ReCOV | vaccine candidate against COVID-19 | ||||
| Recombinant DNA Vaccine | vaccine type that transfects a specific antigen-coding DNA sequence onto the cells of an immunized species | ||||
| Recombivax HB | Merck & Co. | ||||
| RegaVax | COVID-19 yellow fever | ||||
| Remune | |||||
| Respiratory syncytial virus vaccine | vaccine against respiratory syncytial virus (RSV) | respiratory syncytial virus | |||
| RotaTeq | vaccine against rotavirus | Merck KGaA | |||
| Rotarix | vaccine against rotavirus | GSK | |||
| Rudivax | Sanofi Pasteur | rubella | |||
| S-268019 | vaccine candidate against COVID-19 | ||||
| SAIDS vaccines | vaccines or candidate vaccines designed to prevent simian acquired immunodeficiency syndrome | simian acquired immunodeficiency syndrome | |||
| SAV001 | |||||
| SCB-2019 | candidate vaccine against COVID-19 | Clover Biopharmaceuticals Inc. | COVID-19 | ||
| SCIB1 | |||||
| SCTV01C | vaccine candidate against COVID-19 | ||||
| SKYCovione | vaccine candidate against COVID-19 | SK Bioscience | COVID-19 | ||
| SOBERANA 02 | vaccine against COVID-19 | Finlay Institute | COVID-19 | ||
| SPf66 | malaria vaccine | malaria | |||
| Sabin vaccine | live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio | ||||
| Sanofi/GSK SARS-CoV-2 subunit vaccine | experimental COVID-19 vaccine | COVID-19 | |||
| Sanofi–GSK COVID-19 vaccine | recombinant protein subunit vaccine against COVID-19 | ||||
| Sanofi–Translate Bio COVID-19 vaccine | vaccine candidate against COVID-19 | ||||
| Schistosomiasis vaccine | vaccine against Schistosomiasis | schistosomiasis | |||
| Shigella vaccines | vaccines or candidate vaccines used to prevent bacillary dysentery caused by species of Shigella | shigellosis | |||
| Shingrix | recombinant subunit vaccine by GSK | GSK | herpes zoster | ||
| Sinopharm CNBG COVID-19 vaccine | vaccine against COVID-19 | COVID-19 | |||
| Soberana Plus | Vaccine | COVID-19 | |||
| Sputnik Light | Russian single dose viral vector vaccine | intramuscular injection | COVID-19 | ||
| Stamaril | yellow fever vaccine brand | Sanofi | |||
| Stemirna COVID-19 vaccine | vaccine candidate against COVID-19 | ||||
| T-cell vaccine | vaccine designed to induce protective T-cells | ||||
| TA-CD | vaccine used in treatment of addiction | ||||
| TA-NIC | vaccine in development for nicotine addiction | ||||
| TRIVIVAC | Sevapharma | measles mumps rubella | |||
| TURKOVAC | vaccine candidate against COVID-19 | ||||
| Tcelna | |||||
| TroVax | |||||
| Twinrix | vaccine against hepatitis virus A and B | GSK | hepatitis A hepatitis B | ||
| Ty21a | typhoid vaccine | ||||
| UB-612 | experimental COVID-19 vaccine | DASA S.A. | COVID-19 | ||
| University of Queensland COVID-19 vaccine candidate | experimental COVID-19 vaccine | Sypharma CSL Limited Seqirus (global) |
COVID-19 | ||
| V-01 | vaccine candidate against COVID-19 | COVID-19 | |||
| V451 | experimental vaccine targeting SARS-CoV-2 | ||||
| V591 | experimental COVID-19 vaccine | Merck & Co. | COVID-19 | ||
| VBI-2902 | vaccine candidate against COVID-19 | intramuscular injection | COVID-19 | ||
| VSV-EBOV | experimental vaccine against Ebola virus disease | ||||
| VXA-CoV2-1 | COVID-19 vaccine candidate | COVID-19 | |||
| Vaccin diphtérique, tétanique, coquelucheux, poliomyélitique et de l'Haemophilus type b | |||||
| Vaccine failure | |||||
| Valneva COVID-19 vaccine | vaccine candidate against COVID-19 | ||||
| Vaxart COVID-19 vaccine | vaccine candidate against COVID-19 | ||||
| Vaxigrip | Influenza Vaccine | intramuscular injection | Sanofi Pasteur | ||
| Verorab | vaccine against rabies for humans | Sanofi Pasteur | |||
| Versamune-CoV-2FC | COVID-19 vaccine candidate | COVID-19 | |||
| Vi capsular polysaccharide vaccine | vaccine for the prevention of typhoid | typhoid fever | |||
| Virosome vaccines | vaccines using virosomes as antigen delivery system | ||||
| WIBP-CorV | vaccine against COVID-19 | ||||
| Walvax COVID-19 vaccine | vaccine candidate against COVID-19 | COVID-19 | |||
| West China Hospital COVID-19 vaccine candidate | experimental COVID-19 vaccine | ||||
| West Nile Virus vaccine | vaccine or candidate vaccine used to prevent infection with West Nile Virus | West Nile fever | |||
| YF-Vax | yellow fever vaccine brand | Sanofi Pasteur | |||
| Yellow fever 17D vaccine | type of vaccine against yellow fever | yellow fever | |||
| Zhongyianke Biotech–Liaoning Maokangyuan Biotech COVID-19 vaccine | vaccine candidate against COVID-19 | ||||
| Zika fever vaccine | vaccine in development | Zika fever | |||
| Zostavax | live attenuated vaccine against shingles by Merck | Merck & Co. | herpes zoster | ||
| ZyCoV-D | DNA vaccine against COVID-19 | COVID-19 | |||
| acellular vaccines | vaccines produced by using only the antigenic part of the disease causing organism | ||||
| adenovirus vaccine | vaccine against adenovirus | Adenoviridae | |||
| adenovirus-based vaccine | a vaccine based on a non-replicating viral vector | ||||
| anthrax vaccine | vaccine | J07AC | anthrax | ||
| anti-idiotypic vaccine | vaccine | ||||
| artificial virus-like particles | artificially prepared viral sub-particles without viral genetic material | ||||
| attenuated vaccine | vaccine that uses a weakened (or attenuated) form of the germ that causes a disease | ||||
| autovaccine | |||||
| bacTRL-Spike | COVID-19 vaccine candidate | COVID-19 | |||
| bacterial vaccine | suspension of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease | J07A | bacterial infectious disease | ||
| bivalent vaccine | |||||
| cAd3-ZEBOV | experimental vaccine for two ebolaviruses | Orthoebolavirus Ebola hemorrhagic fever | |||
| cancer vaccine | vaccine that either treats existing cancer or prevents development of cancer | cancer | |||
| caries vaccine | vaccine to prevent and protect against tooth decay | dental caries | |||
| cell-based vaccine | |||||
| cholera vaccine | vaccine that is effective at preventing cholera | J07AE01 J07AE02 J07AE |
Cholera | ||
| combined vaccine | two or more vaccines in a single dosage form | ||||
| conjugate vaccine | type of vaccine | ||||
| contraceptive vaccines | vaccines or candidate vaccines used to prevent conception | ||||
| dendritic cell-based cancer vaccines | therapeutic strategy for cancer patients | ||||
| dengue vaccine | vaccine used to prevent dengue fever in humans | dengue fever | |||
| diphtheria vaccine | vaccine against Corynebacterium diphtheriae, the bacterium that causes diphtheria | J07AF | diphtheria | ||
| diphtheria-pertussis-poliomyelitis-tetanus vaccine | J07CA02 | ||||
| diphtheria–tetanus vaccine | combined vaccine used to prevent infection with diphtheria and tetanus toxoid, used in place of DTP vaccine when pertussis vaccine is contraindicated | diphtheria tetanus | |||
| fungal vaccines | suspensions of attenuated or killed fungi administered for the prevention or treatment of infectious fungal disease | fungal infectious disease | |||
| genetically modified vaccine | class of vaccine | ||||
| hAd5-S-Fusion+N-ETSD | COVID-19 vaccine candidate | COVID-19 | |||
| hepatitis A vaccine | vaccine to prevent Hepatitis A | J07BC02 | intramuscular injection | hepatitis A | |
| hepatitis C vaccine | Possible vaccine and research into it | hepatitis C | |||
| hepatitis b virus hbsag surface protein antigen | pharmaceutical drug | ||||
| heptavalent pneumococcal conjugate vaccine | pneumococcal vaccine in which seven pneumococcal serotypes are conjugated individually to a protein complex of Neisseria meningitidis | ||||
| herpes zoster vaccine | any vaccine to prevent shingles | herpes zoster | |||
| heterologous vaccine | |||||
| hexavalent vaccine | single vaccine protecting against six individual diseases | ||||
| hookworm vaccine | vaccine against hookworm | hookworm | |||
| inactivated vaccine | vaccines that uses the killed version of the germ that causes a disease | ||||
| influenza vaccine | vaccine against influenza | J07BB | influenza | ||
| live attenuated influenza vaccine | vaccine that is sprayed into the nose to help protect against influenza | J07BB03 | |||
| live unattenuated vaccines | vaccines prepared from microorganisms without their virulence altered | ||||
| mRNA-1273 vaccine | mRNA vaccine for COVID-19 | J07BX03 | intramuscular injection | Moderna Catalent Pharma Solutions Lonza Group Rovi Bioqual Takeda Pharmaceutical Company |
COVID-19 |
| mRNA-1273.214 vaccine | mRNA vaccine for COVID-19 | ||||
| mRNA-1647 vaccine | mRNA vaccine for Cytomegalovirus infections in development | cytomegaloviral disease | |||
| mRNA-based COVID-19 vaccines | |||||
| malaria vaccine | vaccine that is used to prevent malaria | malaria | |||
| marker vaccine | vaccine which allows for immunological differentiation (or segregation) of infected from vaccinated animals | ||||
| measles vaccine | vaccine used against the disease measles | J07BD01 J07BD |
measles | ||
| meningococcal vaccine | vaccines used to prevent infection by Neisseria meningitidis | J07AH01 J07AH02 J07AH03 J07AH04 J07AH05 J07AH06 J07AH07 J07AH08 J07AH09 J07AH |
intramuscular injection subcutaneous injection |
meningitis meningococcal disease | |
| modified vaccinia Ankara | attenuated vaccine of a poxvirus | Poxviridae | |||
| mumps vaccine | vaccine which prevents mumps | J07BE | mumps | ||
| nanovaccine | vaccine that uses nanonparticles, as carriers and immunologic adjuvants | ||||
| nucleic acid-based vaccine | vaccine formulated with nucleic acids specific for a target antigen | ||||
| oncophage | cancer vaccine | ||||
| parainfluenza vaccines | vaccines or candidate vaccines used to prevent infection with parainfluenza viruses in humans and animals | human parainfluenza | |||
| pentavalent vaccine | combination vaccine with five individual vaccines conjugated into one, intended to actively protect people from multiple diseases. | ||||
| peptide vaccine | peptide which serves to immunize an organism against a pathogen | ||||
| pertussis vaccine | vaccine protecting against whooping cough | J07AJ | pertussis | ||
| plague vaccine | vaccine used against Yersinia pestis | J07AK01 J07AK |
plague Yersinia pestis | ||
| pneumococcal conjugate vaccine | pneumococcal vaccine and a conjugate vaccine | Streptococcus pneumoniae | |||
| pneumococcal polysaccharide vaccine | pneumococcal vaccine | J07AL01 | intramuscular injection | Streptococcus pneumoniae | |
| pneumococcal vaccine | vaccine to prevent infection by the bacterium Stretococcus pneumoniae | J07AL | pneumococcal infection | ||
| polio vaccine | vaccine to prevent poliomyelitis | J07BF01 J07BF03 J07BF |
poliomyelitis | ||
| prophylactic vaccine | vaccine or vaccine candidate for use in preventing disease | ||||
| protein subunit vaccine | vaccine containing recombinant proteins derived from parts of the targeted pathogen | ||||
| protozoan vaccines | suspensions of attenuated or killed protozoa administered for the prevention or treatment of infectious protozoan disease | parasitic protozoa infectious disease | |||
| rabies vaccine | group of vaccines against infection of humans and animals with the rabies virus | J07BG01 J07BG |
rabies rabies virus | ||
| recombinant vaccine | vaccine produced through recombinant DNA technology | ||||
| replicating viral vector vaccine | active artificial (harmless) virus containing target antigen | ||||
| respiratory syncytial virus vaccines | vaccines or candidate vaccines used to prevent infection with respiratory syncytial virus | respiratory syncytial virus infectious disease | |||
| rickettsial vaccine | vaccine for the prevention of diseases caused by species of Rickettsia | rickettsiosis | |||
| rindopepimut | chemical compound | ||||
| rotavirus vaccine | type of vaccine | J07BH | Rotavirus diarrhea | ||
| rubella vaccine | vaccine used to prevent rubella | J07BJ | rubella | ||
| salmonella vaccines | vaccines or candidate vaccines used to prevent infection with salmonella, including vaccines used to prevent typhoid fever or paratyphoid fever and vaccines used to prevent nontyphoid salmonellosis | Salmonella food poisoning | |||
| seasonal influenza vaccine | vaccine against seasonal influenza | ||||
| seviprotimut-L | melanoma cancer vaccine | ||||
| smallpox vaccine | first successful vaccine to be developed | J07BX01 | smallpox | ||
| staphylococcal toxoid | |||||
| staphylococcal vaccine | staphylococcus vaccine | staphylococcal infection | |||
| streptococcal vaccines | vaccines or candidate vaccines used to prevent streptococcal infections | streptococcal infection | |||
| subunit vaccine | vaccine consisting of one or more antigens that stimulate a strong immune response | ||||
| suicidal DNA vaccine | DNA vaccine containing suicidal DNA | ||||
| synthetic vaccine | synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques | ||||
| tetanus vaccine | vaccines used to prevent tetanus | J07AM01 J07AM |
tetanus | ||
| therapeutic vaccine | vaccine or vaccine candidate for use in treatment of a disease | ||||
| tick-borne encephalitis vaccine | preventive medicine | J07BA01 | tick-borne encephalitis | ||
| toxoid | special dead vaccine | ||||
| tozinameran | mRNA vaccine against COVID-19 from BioNTech in cooperation with Pfizer | J07BX | intramuscular injection | Pfizer Rentschler Biopharma SE Behringwerke BioNTech Baxter International |
COVID-19 |
| trypanosomiasis vaccine | vaccine against trypanosomiasis | trypanosomiasis | |||
| tuberculosis vaccines | vaccines to prevent tuberculosis | J07AN | tuberculosis | ||
| tumor antigen vaccine | |||||
| typhoid vaccine | vaccines that prevent typhoid fever | J07AP01 J07AP02 J07AP04 J07AP |
typhoid fever | ||
| typhoid-paratyphoid vaccines | vaccines used to prevent typhoid fever and paratyphoid fever | ||||
| typhus vaccine | vaccines developed to protect against typhus | J07AR | typhus | ||
| universal flu vaccine | vaccine that prevents infection from all strains of the flu | ||||
| vaccine | substance used to stimulate the production of antibodies and provide immunity against one or several diseases,agent of a disease, its products, or a synthetic substitute | J07 | |||
| vaccine against diphtheria, tetanus, and poliomyelitis | J07CA01 | diphtheria tetanus poliomyelitis | |||
| vaccine candidate | pharmaceutical preparation being tested for use in preventing infections | ||||
| vacunes de deleció | |||||
| varicella vaccine | Vaccine to prevent chickenpox | chickenpox Human herpesvirus 3 herpes zoster | |||
| varicella-zoster virus strain oka/merck live antigen | pharmaceutical drug | ||||
| vaxchora | type of colera vaccine | oral administration | Cholera | ||
| vector-based vaccine | type of vaccine | ||||
| viral hepatitis vaccines | vaccine raised against any virus or viral derivative that causes hepatitis | J07BC | viral hepatitis | ||
| viral vaccines | suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease | J07B | viral infectious disease | ||
| viral vector vaccine | type of vaccine | ||||
| virus-like particle | virion that lacks nucleic acid | ||||
| virus-like particle vaccine | vaccine using supra-molecular structures composed of multiple copies of recombinantly expressed viral structural proteins | ||||
| yellow fever vaccine | vaccine that protects against yellow fever | J07BL01 J07BL |
yellow fever | ||
| zorecimeran | candidate vaccine against COVID-19 | COVID-19 | |||
| Совигрипп | influenza | ||||
| スギ花粉米 | rice-based edible vaccine | ||||
| 万能ワクチン |
End of automatically generated list.